Home›Companies›Healthcare›Opus KSD

Opus KSD, Inc.

Makes absorbable skin closure devices for surgeons treating surgical incisions.

Updated Nov 9, 2026·Latest SEC filing Oct 1, 2026·Suggest an edit

About Opus KSD

Opus KSD is a private company based in Pembroke, Massachusetts. It has reported $1,480,801 raised in three offerings on Form D since March 2016. Its chief executive is Charles Rogers.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 23, 2026Oct 1, 2026$680,801fully sold16$42,550EquityRule 506(b)Form D ↗
Oct 18, 2023Oct 31, 2023$300,000of $1.0M target3$100KEquityRule 506(b)Form D ↗
Feb 29, 2016Mar 8, 2016$500,000of $1.0M target1$500KEquityRule 506(b)Form D ↗
Total, three offerings$1,480,801

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Opus KSD's Form D filed Oct 1, 2026.

CR
Charles Rogers
CEO and director
SA
Saud Alturki
Director
PA
WS
Wei Shen
Director

Earlier filings also listed Saud Abdulaziz al-Turki (director, last listed Oct 2023).

Sources

  1. SECOpus KSD, Inc. filing history